About Metaceutic
Metaceutic was founded in 2019 with a simple but bold idea: that the root cause of the world's most pressing lifestyle diseases could be addressed by understanding and improving the human gut.
The beginning
In 2019, after more than a decade seeding and driving innovation at the highest level in the pharmaceutical industry, Ali Kazemi left a senior position at Novo Nordisk to found Metaceutic.
He did so with a sincere motivation to change the healthcare agenda — emphasising the need and possibilities to build products and tools that can help address the root cause of an array of global lifestyle epidemics.
The conviction
At Metaceutic, the focus is not on treating disease once it has manifested — but on addressing its root cause before it does. By combining metagenomics with AI-driven prognostics, the company develops solutions that enable earlier, more precise intervention in chronic inflammatory conditions.
The conviction driving Metaceutic is that the future of healthcare lies in true prognostics and proactive health management — not in late-stage diagnostics and symptomatic treatment. The gut microbiome, as one of the most data-rich and modifiable systems in the human body, sits at the centre of this shift.
The focus
Metaceutic is particularly focused on conditions rooted in chronic inflammation — including mental health disorders and metabolic disease — that are particularly hard to reverse once established. The earlier we take charge of our own health, the better the outcomes for everyone.
"The gut is as unique as a fingerprint.— Dr. Ali Kazemi, Founder & CEO
It deserves the same attention."
Three principles guide everything we do — from how we build our science to how we work with partners.
We pursue bold ideas that have the potential to change the way we understand, prevent, and treat health conditions — always starting from real human needs.
We believe in the power of open innovation and the importance of partnerships in accelerating progress and driving impact that matters at scale.
Our products and services are grounded in rigorous research and cutting-edge technology — validated by thousands of real-world customers before we scale.